PHS
LRCX icon

PFM Health Sciences’s Lam Research LRCX Stock Holding History

PFM Health Sciences’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,986,460
Closed -$90.7M – 95
2016
Q1 		$90.7M Buy
10,986,460
+2,938,130
+37% +$21.4M 2.8% 9
2015
Q4 		$63.9M Buy
+8,048,330
New +$60.5M 1.94% 19

Other funds holding LRCX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PFM Health Sciences's LRCX Position: Q2 2016 in Review

PFM Health Sciences sold out of Lam Research (LRCX) in Q2 2016, closing a stake of 10,986,460 shares — an estimated $90.7M sold.

PFM Health Sciences first reported a position in LRCX in Q4 2015 and held it in 2 quarters. The position peaked at $90.7M in Q1 2016. 585 funds tracked by Wall St. Rank hold LRCX as of Q2 2016.

  • PFM Health Sciences reported no remaining Lam Research position as of Q2 2016 after selling out during the quarter.
  • PFM Health Sciences sold 10,986,460 Lam Research shares in Q2 2016, an estimated $90.7M.
  • PFM Health Sciences first reported a position in Lam Research in Q4 2015 and held it in 2 quarters.
  • PFM Health Sciences's Lam Research position peaked at $90.7M in Q1 2016.
  • 585 funds tracked by Wall St. Rank held Lam Research as of Q2 2016.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.